Lin T. Gui

19 Yuquan Road
Shijingshan, 100039, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 182 publications

Anlotinib Plus Sintilimab for BRAFV600E Negative Unresectable or Metastatic Anaplastic Thyroid Carcinoma: A Single-Center, Single-Arm, Phase 2 Trial.

Anlotinib Plus Sintilimab for BRAFV600E Negative Unresectable or Metastatic Anaplastic Thyroid Carcinoma: A Single-Center, Single-Arm, Phase 2 Trial.

Journal: Thyroid : official journal of the American Thyroid Association

Published: January 24, 2026

Neoadjuvant ctDNA-MRD monitoring uncovers occult progression despite radiologic response in locally advanced hypopharyngeal carcinoma: a case report.

Neoadjuvant ctDNA-MRD monitoring uncovers occult progression despite radiologic response in locally advanced hypopharyngeal carcinoma: a case report.

Journal: Frontiers in oncology

Published: November 20, 2025

Neoadjuvant immunochemotherapy followed by definitive radiotherapy in locally advanced head and neck squamous cell carcinoma: two-year survival outcomes.

Neoadjuvant immunochemotherapy followed by definitive radiotherapy in locally advanced head and neck squamous cell carcinoma: two-year survival outcomes.

Journal: Cancer immunology, immunotherapy : CII

Published: November 08, 2025

Socioeconomic status and cognitive function in older adults: the mediating roles of social activity and loneliness in three aging cohorts.

Socioeconomic status and cognitive function in older adults: the mediating roles of social activity and loneliness in three aging cohorts.

Journal: BMC public health

Published: November 03, 2025

Pembrolizumab combined with nab-paclitaxel and platinum in recurrent/metastatic HNSCC: efficacy, safety, and survival predictive model.

Pembrolizumab combined with nab-paclitaxel and platinum in recurrent/metastatic HNSCC: efficacy, safety, and survival predictive model.

Journal: ESMO open

Published: October 27, 2025

Genomic profiling and HER2-targeted therapy: a case series of Chinese salivary duct carcinoma patients and its clinical implications.

Genomic profiling and HER2-targeted therapy: a case series of Chinese salivary duct carcinoma patients and its clinical implications.

Journal: Frontiers in oncology

Published: October 17, 2025

Expert consensus on the combination of Anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma.

Expert consensus on the combination of Anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma.

Journal: Cancer treatment reviews

Published: September 08, 2025

Digital spatial profiling uncovers transcriptomic features of distinct plasma cell-like phenotypes in diffuse large B-cell lymphoma.

Digital spatial profiling uncovers transcriptomic features of distinct plasma cell-like phenotypes in diffuse large B-cell lymphoma.

Journal: Blood advances

Published: August 18, 2025

Efficacy and safety of SCT200 in patients with recurrent or metastatic head and neck squamous cell carcinoma after platinum failure: A phase 2 study.

Efficacy and safety of SCT200 in patients with recurrent or metastatic head and neck squamous cell carcinoma after platinum failure: A phase 2 study.

Journal: Cancer pathogenesis and therapy

Published: July 04, 2025

Clinical pharmacist-led Antimicrobial Stewardship under volume-based procurement: a retrospective quasi-experimental study on rational use and resistance control.

Clinical pharmacist-led Antimicrobial Stewardship under volume-based procurement: a retrospective quasi-experimental study on rational use and resistance control.

Journal: Antimicrobial stewardship & healthcare epidemiology : ASHE

Published: May 28, 2025

Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 study.

Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 study.

Journal: Signal transduction and targeted therapy

Published: May 19, 2025

Neoadjuvant toripalimab combined with chemotherapy in locally advanced HNSCC.

Neoadjuvant toripalimab combined with chemotherapy in locally advanced HNSCC.

Journal: Frontiers in oncology

Published: February 06, 2025

Showing 1-12 of 182

Last Updated: 09/26/2026